Why is GBS stock trading higher today?
Shares of GBS stock are trading higher after a clinical study at Harvard University yielded positive results for the company's antibody test. The post GBS Stock: The Covid Antibody Test News Shooting GB...
What are GBS earnings expected to grow this year?
Earnings for GBS are expected to grow in the coming year, from ($0.60) to ($0.26) per share. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks.
Where is GBS Inc based?
The company was founded in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Is GBS stock a buy?
During the day the stock fluctuated 27.59% from a day low at $0.62 to a day high of $0.79. The price has fallen in 6 of the last 10 days and is down by -4.66% for this period....Predicted Opening Price for GBS Inc. of Wednesday, July 13, 2022.Fair opening price July 13, 2022Current price$0.71$0.71 (Overvalued)
Is GBS a good stock?
GBS has an overall F rating, which translates to Strong Sell in our proprietary POWR Ratings system. The POWR Ratings are calculated by considering 118 distinct factors, with each factor weighted to an optimal degree. The stock has a D grade for Growth, which is consistent with its bleak financial growth.
GBS Inc. to Present Second Quarter 2022 Financial Results and Recent Corporate Update on February 10
Company to Host Conference Call & Webcast at 4:30 p.m. ET Company to Host Conference Call & Webcast at 4:30 p.m. ET
GBS Inc. to Participate in the Upcoming January Virtual Investor Conferences
NEW YORK, Dec. 20, 2021 (GLOBE NEWSWIRE) -- GBS (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-...
GBS Inc. Announces Application for FDA Breakthrough Device Designation to Fast Track Rapid Saliva Glucose Test
NEW YORK, Dec. 13, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at p...
GBS Stock: The Covid Antibody Test News Shooting GBS Shares Higher Today
Shares of GBS stock are trading higher after a clinical study at Harvard University yielded positive results for the company's antibody test. The post GBS Stock: The Covid Antibody Test News Shooting GB...
GBS Shares Are Rallying On Plans For COVID-19 Antibody Trials After Validation Study
GBS Inc (NASDAQ:GBS) will prepare for clinical trials of its rapid SARS-CoV-2 (COVID-19) Antibody test following the recent successful completion of a clinical validation study. As previously referenced...
GBS Inc. Announces Plans for Clinical SARS-CoV-2 Antibody Trials Following Validation Study
NEW YORK, Nov. 30, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at p...
GBS Inc. to Present First Quarter 2022 Financial Results and Recent Corporate Update on November 11
Company to Host Conference Call & Webcast at 4:30 p.m. ET Company to Host Conference Call & Webcast at 4:30 p.m. ET
About GBS
GBS Inc. operates as a biosensor diagnostic technology company. Its principal product is Saliva Glucose Biosensor, a saliva glucose monitoring system for diabetes management. The company also focuses on developing other diagnostic tests in the areas of biochemistry, tumor markers, immunology, hormones, and other biomarkers.
Headlines
How many GBs is Dying Light 2? File size, system requirements, and more
GBS (NYSE:GBS) Frequently Asked Questions
GBS is scheduled to release its next quarterly earnings announcement on Friday, May 13th 2022. View our earnings forecast for GBS.
News
GBS Inc is a United States-based company engaged in manufacturing of Saliva Glucose Biosensor (SGB). SGB uses saliva to measure glucose non-invasively. The Saliva Glucose Test consists of the SGB which is a single-use disposable saliva biosensor and the software app that interfaces the SGB with its digital information system.
Trending Stocks
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices. Stock prices may also move more quickly in this environment.